Preliminary evaluation of a smartphone application (DelApp) for identification of delirium in sub-Saharan Africa.

IF 3.8 4区 医学 Q1 Medicine Acta Neuropsychiatrica Pub Date : 2023-06-22 DOI:10.1017/neu.2023.29
Stella-Maria Paddick, Editruda Gamassa, Nuru Mwaluwinga, Grace Lewis, Ashanti Duinmaijer, Sarah Urasa, Laura Tucker, Elizabeta Blagoja Mukaetova-Ladinska, Glynis Cosker, Marieke Dekker, Aloyce Kisoli, Jane Cletus, Caroline Lissu, Catherine Dotchin, William K Gray, Richard Walker
{"title":"Preliminary evaluation of a smartphone application (DelApp) for identification of delirium in sub-Saharan Africa.","authors":"Stella-Maria Paddick,&nbsp;Editruda Gamassa,&nbsp;Nuru Mwaluwinga,&nbsp;Grace Lewis,&nbsp;Ashanti Duinmaijer,&nbsp;Sarah Urasa,&nbsp;Laura Tucker,&nbsp;Elizabeta Blagoja Mukaetova-Ladinska,&nbsp;Glynis Cosker,&nbsp;Marieke Dekker,&nbsp;Aloyce Kisoli,&nbsp;Jane Cletus,&nbsp;Caroline Lissu,&nbsp;Catherine Dotchin,&nbsp;William K Gray,&nbsp;Richard Walker","doi":"10.1017/neu.2023.29","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>In sub-Saharan Africa, there are no validated screening tools for delirium in older adults, despite the known vulnerability of older people to delirium and the associated adverse outcomes. This study aimed to assess the effectiveness of a brief smartphone-based assessment of arousal and attention (DelApp) in the identification of delirium amongst older adults admitted to the medical department of a tertiary referral hospital in Northern Tanzania.</p><p><strong>Method: </strong>Consecutive admissions were screened using the DelApp during a larger study of delirium prevalence and risk factors. All participants subsequently underwent detailed clinical assessment for delirium by a research doctor. Delirium and dementia were identified against DSM-5 criteria by consensus.</p><p><strong>Results: </strong>Complete data for 66 individuals were collected of whom 15 (22.7%) had delirium, 24.5% had dementia without delirium, and 10.6% had delirium superimposed on dementia. Sensitivity and specificity of the DelApp for delirium were 0.87 and 0.62, respectively (AUROC 0.77) and 0.88 and 0.73 (AUROC 0.85) for major cognitive impairment (dementia and delirium combined). Lower DelApp score was associated with age, significant visual impairment (<6/60 acuity), illness severity, reduced arousal and DSM-5 delirium on univariable analysis, but on multivariable logistic regression only arousal remained significant.</p><p><strong>Conclusion: </strong>In this setting, the DelApp performed well in identifying delirium and major cognitive impairment but did not differentiate delirium and dementia. Performance is likely to have been affected by confounders including uncorrected visual impairment and reduced level of arousal without delirium. Negative predictive value was nevertheless high, indicating excellent 'rule out' value in this setting.</p>","PeriodicalId":7066,"journal":{"name":"Acta Neuropsychiatrica","volume":null,"pages":null},"PeriodicalIF":3.8000,"publicationDate":"2023-06-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Neuropsychiatrica","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1017/neu.2023.29","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: In sub-Saharan Africa, there are no validated screening tools for delirium in older adults, despite the known vulnerability of older people to delirium and the associated adverse outcomes. This study aimed to assess the effectiveness of a brief smartphone-based assessment of arousal and attention (DelApp) in the identification of delirium amongst older adults admitted to the medical department of a tertiary referral hospital in Northern Tanzania.

Method: Consecutive admissions were screened using the DelApp during a larger study of delirium prevalence and risk factors. All participants subsequently underwent detailed clinical assessment for delirium by a research doctor. Delirium and dementia were identified against DSM-5 criteria by consensus.

Results: Complete data for 66 individuals were collected of whom 15 (22.7%) had delirium, 24.5% had dementia without delirium, and 10.6% had delirium superimposed on dementia. Sensitivity and specificity of the DelApp for delirium were 0.87 and 0.62, respectively (AUROC 0.77) and 0.88 and 0.73 (AUROC 0.85) for major cognitive impairment (dementia and delirium combined). Lower DelApp score was associated with age, significant visual impairment (<6/60 acuity), illness severity, reduced arousal and DSM-5 delirium on univariable analysis, but on multivariable logistic regression only arousal remained significant.

Conclusion: In this setting, the DelApp performed well in identifying delirium and major cognitive impairment but did not differentiate delirium and dementia. Performance is likely to have been affected by confounders including uncorrected visual impairment and reduced level of arousal without delirium. Negative predictive value was nevertheless high, indicating excellent 'rule out' value in this setting.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
初步评估智能手机应用程序(DelApp)识别谵妄在撒哈拉以南非洲。
目的:在撒哈拉以南非洲,尽管已知老年人易患谵妄和相关不良后果,但仍没有经过验证的老年人谵妄筛查工具。本研究旨在评估基于智能手机的唤醒和注意力简短评估(DelApp)在识别坦桑尼亚北部一家三级转诊医院内科收治的老年人谵妄中的有效性。方法:在对谵妄患病率和危险因素进行更大规模的研究期间,使用DelApp对连续入院患者进行筛选。随后,所有参与者都接受了一名研究医生对谵妄的详细临床评估。谵妄和痴呆被一致认定为违反DSM-5标准。结果:收集了66例患者的完整资料,其中15例(22.7%)患有谵妄,24.5%患有无谵妄的痴呆,10.6%患有谵妄合并痴呆。DelApp对谵妄的敏感性和特异性分别为0.87和0.62 (AUROC为0.77),对严重认知障碍(痴呆和谵妄合并)的敏感性和特异性分别为0.88和0.73 (AUROC为0.85)。较低的DelApp评分与年龄、明显的视力障碍相关(结论:在这种情况下,DelApp在识别谵妄和严重认知障碍方面表现良好,但不能区分谵妄和痴呆。表现很可能受到混杂因素的影响,包括未矫正的视力障碍和无谵妄的觉醒水平降低。然而,阴性预测值很高,表明在这种情况下具有出色的“排除”价值。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta Neuropsychiatrica
Acta Neuropsychiatrica 医学-精神病学
CiteScore
8.50
自引率
5.30%
发文量
30
审稿时长
6-12 weeks
期刊介绍: Acta Neuropsychiatrica is an international journal focussing on translational neuropsychiatry. It publishes high-quality original research papers and reviews. The Journal''s scope specifically highlights the pathway from discovery to clinical applications, healthcare and global health that can be viewed broadly as the spectrum of work that marks the pathway from discovery to global health.
期刊最新文献
Cannabidiol modulates contextual fear memory consolidation in animals with experimentally induced type-1 diabetes mellitus. Role of T and B lymphocyte cannabinoid type 1 and 2 receptors in major depression and suicidal behaviours. Cannabidiol negatively modulates adenosine A2A receptor functioning in living cells. The effects of cannabidiol on behavioural and oxidative stress parameters induced by prolonged haloperidol administration. Psychiatric sequelae after SARS-Cov-2 infection: trajectory, predictors and associations in a longitudinal Australian cohort.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1